Better Fintech Stock: Upstart vs. Affirm

Both Upstart (UPST) and Affirm (AFRM) shares are down roughly 36% year-to-date. Upstart reported loan originations +86%, revenue +64% and $18.6M net income (third straight profitable quarter); Affirm posted GMV +36%, revenue +30% and net income +61% YoY. Both trade at about 58x earnings (down from Dec P/Es of 168 for Upstart and 107 for Affirm) and face credit-quality risk if defaults rise in 2026, but each has applied for bank charters that could lower funding costs and boost earnings; the author favors Upstart’s AI-driven, asset-light model as the better long-term option.

Analysis

The strategic pivot from pure-play servicing to holding lending assets is a regime change for fintechs — it swaps fee-based, highly scalable revenue for interest-rate- and capital-sensitive economics. That transition will re-price these companies along bank metrics (NIM, CET1-equivalent capital drag, deposit beta) rather than pure SaaS multiples, creating a two-stage rerating where near-term optionality matters more than current growth.

Second-order winners will be firms that supply low-cost funding pipes and securitization tech (warehouse lenders, non-bank ABS managers) because balance-sheet origination increases demand for short-term wholesale funding and repeatable securitization — expect widening business for those providers if originations shift in-house. Conversely, incumbent regional banks that currently monetize distribution and servicing relationships will see fee attrition and potential margin compression, pressuring legacy deposit franchises to reprice or bundle services.

Key risks are regulatory capital surprise, higher deposit beta than modeled, and credit losses that compound via retained-interest exposure; any one of these can flip the long case in 3–9 months if macro weakens. The consensus underestimates the governance and compliance costs of becoming a regulated balance-sheet lender: operational controls, capital stress testing, and limitations on third-party data sharing can slow product expansion and increase marginal cost per loan.

A practical implication: optionality around the charter/permission milestone should be monetized with asymmetric instruments (calls or pair trades) rather than outright long exposure; pure equity longs will be binary to funding and credit cycles. Position sizing needs to reflect the newly correlated exposure to both interest-rate moves and credit spreads — treat these fintechs as hybrid bank-credit plays, not high-growth software stocks.

Key Decisions for Investors

• Pair trade (medium-term, 6–12 months): Long UPST equity (size 1.0x) / Short AFRM equity (size 0.7x) to express conviction in better unit economics and superior AI-driven credit selection. Target: +60% relative upside if UPST captures higher-margin loans and AFRM faces higher funding costs; Stop-loss: -30% relative move against the pair. Rationale: hedges macro/regulatory beta while isolating differential execution.
• Options asymmetric (3–9 months): Buy 9–12 month UPST call spread (buy ATM call, sell 1.5x OTM call) sized to risk 2–3% of book. Reward: 3–4x payoff if financing and credit cycle improve; capped cost limits downside if deposit funding or credit surprises emerge. Use to monetize optionality without taking full equity downside.
• Short funding-sensitivity hedge (3 months): Buy protection via AFRM or UPST short-dated (30–90d) implied-volatility call options if deposit beta or credit headlines spike — these act as crisis insurance for long positions. Size to cover estimated drawdown from a 100–200bp widening in fintech funding spreads (~cover 20–30% portfolio exposure).
• Event-based trade (weeks–months): If a regulatory milestone is announced, rotate profits from options into longer-dated UPST equity or bullish convertible paper; conversely if regulator imposes material capital requirements or restriction, reduce exposure by 50% and pick up CDS or senior-bank proxies. Frame every position around explicit funding and capital-readout triggers.